Clinical Trials Browser

Phase 2 × Neuroendocrine Tumors × MK 2206 × Clear all

NCT01169649 2016-02-18

Study of MK-2206 in Patients With Metastatic Neuroendocrine Tumors (NET)

Phase 2 Completed

11 enrolled 6 charts

Neuroendocrine Tumors